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Background: Large, population-based administrative healthcare databases can be used to identify patients with
chronic kidney disease (CKD) when serum creatinine laboratory results are unavailable. We examined the validity of
algorithms that used combined hospital encounter and physician claims database codes for the detection of CKD
in Ontario, Canada.
Methods: We accrued 123,499 patients over the age of 65 from 2007 to 2010. All patients had a baseline serum
creatinine value to estimate glomerular filtration rate (eGFR). We developed an algorithm of physician claims and
hospital encounter codes to search administrative databases for the presence of CKD. We determined the
sensitivity, specificity, positive and negative predictive values of this algorithm to detect our primary threshold of
CKD, an eGFR <45 mL/min per 1.73 m2 (15.4% of patients). We also assessed serum creatinine and eGFR values in
patients with and without CKD codes (algorithm positive and negative, respectively).
Results: Our algorithm required evidence of at least one of eleven CKD codes and 7.7% of patients were algorithm
positive. The sensitivity was 32.7% [95% confidence interval: (95% CI): 32.0 to 33.3%]. Sensitivity was lower in
women compared to men (25.7 vs. 43.7%; p <0.001) and in the oldest age category (over 80 vs. 66 to 80; 28.4 vs.
37.6 %; p < 0.001). All specificities were over 94%. The positive and negative predictive values were 65.4% (95% CI: 64.4
to 66.3%) and 88.8% (95% CI: 88.6 to 89.0%), respectively. In algorithm positive patients, the median [interquartile range
(IQR)] baseline serum creatinine value was 135 μmol/L (106 to 179 μmol/L) compared to 82 μmol/L (69 to 98 μmol/L)
for algorithm negative patients. Corresponding eGFR values were 38 mL/min per 1.73 m2 (26 to 51 mL/min per 1.73
m2) vs. 69 mL/min per 1.73 m2 (56 to 82 mL/min per 1.73 m2), respectively.
Conclusions: Patients with CKD as identified by our database algorithm had distinctly higher baseline serum creatinine
values and lower eGFR values than those without such codes. However, because of limited sensitivity, the prevalence
of CKD was underestimated.
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Chronic kidney disease (CKD) is a permanent reduction
in kidney function that can progress to end stage renal
disease (ESRD) requiring either ongoing dialysis or a
kidney transplant to maintain life. CKD also affects how
many medications are eliminated from the body [1]. In
routine practice a laboratory serum creatinine value is
used to estimate kidney function by incorporating it into
a formula to estimate the glomerular filtration rate and
establish whether a patient has CKD. However, in some
situations there is an interest in identifying CKD using
healthcare database codes when laboratory values are not
available. Codes in these databases have their limitations
and knowledge of their validity guides their optimal
use [2]. The purpose of the current study was to develop
and examine the validity of algorithms using hospital
encounter (International Classification of Diseases, 10th
revision [ICD-10]) codes and physician claim codes for the
detection of CKD assessed against a reference standard of
estimated glomerular filtration rate (eGFR) determined
with laboratory values. We hypothesized, based on
validations done for other laboratory-based conditions by
our research group, that our best performing algorithm
would demonstrate limited sensitivity but excellent
specificity for the identification of CKD [3-6]. As
suggested in the literature, we also hypothesized that code
sensitivity would be lower in women compared to men,
and lowest in the oldest age category [7].
Methods
Study design
We conducted a retrospective, population-based validation
study using linked administrative databases housed at
the Institute for Clinical Evaluative Sciences (ICES). The
province of Ontario, Canada has approximately 13 million
residents, 14% of whom are 65 years of age or older [8].
Residents of Ontario have universal access to hospital care
and physician services and those 65 years of age or older
have universal prescription drug coverage. Due to the
availability of laboratory data, this study was restricted to
those individuals aged 65 and older in Southwestern
Ontario, which consisted of 80,000 individuals in the year
2006 [9]. We gathered serum creatinine values from 12
regional hospitals in Southwestern Ontario as well as
outpatient laboratories. We examined the validity of our
primary database algorithm consisting of ICD-10 and
physician claims diagnostic codes for detecting CKD by
comparing it to eGFR (derived from serum creatinine
laboratory values) as the reference standard. Codes of our
primary database algorithm were finalized after testing
several codes alone or in combination (described below).
The reporting of this study follows guidelines for studies
of diagnostic accuracy (Additional file 1) [10]. We
conducted our study according to a pre-specified protocolthat was approved by the institutional review board at
Sunnybrook Health Sciences Centre (Toronto, Ontario).
Data sources
We ascertained the presence of relevant comorbidities
for exclusions and baseline characteristics using patient
records from seven linked databases. The Ontario
Drug Benefit (ODB) Plan database contains records of
prescriptions for individuals 65 years or older from
outpatient pharmacies. The dispensing of medications for
patients aged 65 and older is accurately recorded in
this database with an error rate of <1% [11]. The
Canadian Institute for Health Information (CIHI) National
Ambulatory Care Reporting System (NACRS) contains
ambulatory care information on emergency room
visits, outpatient procedures, and day surgeries. The
CIHI Discharge Abstract Database (CIHI-DAD) captures
procedures and diagnoses for hospitalized patients in
Ontario. The Ontario Health Insurance Plan (OHIP)
database contains all physician claims for medical services
covered under the provincial health insurance plan.
Lastly, the Registered Persons Database (RPDB) contains
demographic information, such as birth date and sex, for
all Ontario residents who have ever been covered by the
provincial healthcare plan.
In addition to the administrative databases described
above, we also used two laboratory datasets for baseline
serum creatinine values. An electronic medical record,
CernerW (Kansas City, Missouri, USA), contains inpatient,
outpatient, and emergency department laboratory
values for 12 hospitals in Southwestern Ontario [12].
Additionally, Gamma Dynacare provided all outpatient
serum creatinine values for patients serviced by this
laboratory provider in Southwestern Ontario. We have
successfully used these laboratory datasets linked to
administrative data in previous studies [13-15].
Patients
We accrued patients at the time of an outpatient
prescription for any medication between July 1, 2007
and December 31, 2010. We focused on outpatient
prescriptions based on the assumption that the outpatient
setting is most likely to capture individuals at time of
clinical stability. In addition, administrative data are often
used for pharmacoepidemiologic studies, in which having
a prescription is paramount. In Ontario, prescription drug
coverage is a universal benefit for patients 65 years of
age or older. Almost all older residents in Ontario were
expected to have at least one prescription medication
dispensed through the provincial drug plan over the
accrual period. Patients with multiple prescriptions
during the accrual period could only be selected once
for cohort entry. To be included, patients must have had
at least one serum creatinine laboratory test in the year
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Southwestern Ontario. Serum creatinine testing amongst
older adults is fairly ubiquitous in Ontario, with most
individuals having at least one outpatient serum creatinine
test in a given year [16]. We considered only patients 66
years of age or older in this study to allow for a minimum
of one year of baseline prescription information from the
provincial drug plan. We excluded laboratory tests where
patients were hospitalized up to two days prior to their
prescription date to ensure we captured prescriptions first
initiated in the outpatient setting. As we were interested
in detecting CKD prior to any treatment for kidney failure,
we also excluded patients who received dialysis in the year
prior or a kidney transplant in the five years prior to the
prescription date.
CKD Database algorithm (Diagnostic test)
Diagnostic codes and their associated attributes are
recorded in health administrative databases. For hospital
encounters in Canada, trained coders follow specific
rules and guidelines set out when assigning diagnostic
codes based on a patient’s chart. They cannot interpret
any diagnostic tests, such as x-rays or laboratory values,
unless a diagnosis is specifically written by the physician
in the medical chart [17]. For physician claims, typically
clerical personnel employed by a physician submit billing
and diagnosis codes for each patient seen in order for
the physician to be paid for services provided.
To develop our algorithm to detect CKD two nephrol-
ogists reviewed all available ICD-10 and OHIP diagnostic
database codes and identified 55 that were deemed
potentially relevant (Additional file 1). An individual was
classified as algorithm positive for CKD if a code appeared
at least once in the five years prior to the outpatient
prescription date. We finalized elements of our primary
database algorithm using a process described below
(see ‘Data Analysis’ section).
Kidney function laboratory values (Reference standard)
GFR was estimated from serum creatinine using the
CKD-EPI equation [18,19]. We chose the most recent
serum creatinine value from any setting prior to the
outpatient prescription as our test value. If this value
was done while a patient was in hospital, this was the
most recent value prior to discharge (which helps avoid
temporary elevated serum creatinine values due to acute
kidney injury where physicians wait for resolution prior
to hospital discharge).
Although a recently revised staging system for CKD
does exist its use in the elderly remains controversial
[20]. Nonetheless, stage IIIb CKD or more is defined by
an estimated glomerular filtration rate (eGFR) <45 mL/min
per 1.73 m2 and is accepted as a clinically important
reduction in kidney function in elderly patients [21].Furthermore, when creatinine tests are repeated, eGFR
values <45 mL/min per 1.73 m2 in the outpatient setting
are more stable compared to higher eGFR values [22]. For
these reasons we selected our primary threshold to define
CKD as an eGFR <45 mL/min per 1.73 m2. However, in
additional analyses we also examined thresholds of <60
and <30 mL/min per 1.73 m2. We used thresholds rather
than mutually exclusive groups to mimic how inferences
about the types of patients detected by the algorithm will
be made in practice.
Data analysis
We calculated the sensitivity, specificity, positive predictive
value, and negative predictive value of each coding
algorithm for each eGFR threshold. We developed a two
by two contingency table for each code to assess its
validity for detecting CKD (see Additional file 1 for
an example). We examined the validity of each code
on its own or combined within an algorithm using the
Boolean operator “OR”. For our final primary algorithm
we combined codes to include those that either had a
sensitivity of at least 3% or were conceptually similar to
included codes. Because serum creatinine and eGFR
are continuous variables, we also contrasted the mean,
median, and interquartile ranges of serum creatinine and
eGFR values for those who were CKD algorithm positive
(i.e. presence of at least one of codes in our final algo-
rithm) compared to those who were CKD algorithm
negative (i.e. absence of all of the codes in our final
algorithm). We performed additional analyses to further
understand the attributes of the CKD algorithm. These
included restricting to outpatient only laboratory values,
assessing at least two codes in the look-back window,
and applying different combinations of renal codes. We
calculated 95% confidence intervals (CI) for single
proportions using the Wilson Score method [22]. We
expressed serum creatinine and eGFR values as medians
with interquartile ranges (IQR). We performed all analyses
using SAS version 9.2 (SAS Institute Incorporated, Cary,
North Carolina, USA, 2008).
Results
Our study included 123,499 patients (patient selection
presented in Additional file 1). Patient baseline charac-
teristics are presented in Table 1. The median age was 75
years and 54% of the patients were women. Approximately
23% of our cohort had diabetes, while 40% had coronary
artery disease. A total of 15.4% of patients had a measured
eGFR study value of <45 mL/min per 1.73 m2. Seventy five
percent of serum creatinine values used to estimate GFR
were taken from an outpatient laboratory, with the
remaining coming from a hospital setting. Of note, 52,081
(42.2%) patients also had an additional serum creatinine
test in the 90 to 365 days prior to their study serum
Table 1 Baseline characteristics
N = 123499
Demographics
Age, years, median (IQR) 75 (70–81)
Women, n (%) 67207 (54.4)
Income quintile, n (%)
One (lowest) 24803 (20.1)
Two 24607 (19.9)
Three (middle) 25016 (20.3)
Four 23112 (18.7)
Five (highest) 24837 (20.1)
Rural Location, n (%) 25707 (20.8)
Comorbidities, n (%)
Coronary artery disease¶ 49027 (39.7)
Diabetes mellitus£ 28759 (23.3)
Heart failure 20259 (16.4)
Peripheral vascular disease 2730 (2.2)
Stroke/Transient ischemic attack 4812 (3.9)
Medication use in prior 6 months, n (%)
Angiotensin-converting enzyme inhibitors 49635 (40.2)
Angiotensin-receptor blockers 28438 (23.0)
Beta blockers 47051 (38.1)
Calcium channel blockers 40600 (32.9)
Loop diuretics 22860 (18.5)
NSAIDs(excluding aspirin) 26478 (21.4)
Warfarin 14967 (12.1)
Potassium sparing diuretics 9948 (8.1)
Statins 65168 (52.8)
Thiazide diuretics 27448 (22.2)
Baseline Laboratory Measurements*
Serum creatinine μmol/L, median (IQR) 84 (70–102)






Serum sodium mmol/L, median, (IQR) 140 (138–142)
Serum potassium mmol/L, median (IQR) 4.2 (3.9-4.6)
Proteinuria (dipstick value) g/L
Category, n (%)





Abbreviations: IQR, interquartile range; NSAIDs, non-steroidal anti-
inflammatory drugs; eGFR, estimated glomerular filtration rate.
¶ Coronary artery disease includes receipt of coronary artery bypass graft
surgery, percutaneous coronary intervention and diagnoses of angina.
£ Assessed by diabetic medication use in previous 6 months.
* All patients had a serum creatinine measurement. A total of 109,743 (88.9%),
and 111,304 (90.1%) patients had a serum sodium and potassium
measurement in the year prior to cohort entry, respectively while 26,483
(21.4%) patients had a urine dipstick protein value. The most recent values
prior to the prescription date were used.
ŦeGFR was calculated using the CKD-Epi equation.
CKD-Epi equation:141 x min([serum creatinine in umol/L /88 · 4 ]/κ, 1)α x max
([serum creatinine in umol/L / 88 · 4]/κ, 1)-1·209 x 0 · 993Age x 1 · 018 [if female] x
1 · 159 [if African American] κ = 0 · 7 for females and 0 · 9 for males, α = −0 · 329
for females and −0 · 411 for males, min = the minimum of Scr/κ or 1, max = the
maximum of Scr/κ or 1.Racial information was not available in our data sources
and all patients were assumed not to be of non African-Canadian race. This was
a reasonable assumption; as of 2006, African-Canadians represented <7% of the
Ontario population. Source:http://www12.statcan.ca/census-recensement/2006/
dp-pd/hlt/97-562/index.cfm?Lang=E.
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(IQR) difference in eGFR between the study and prior test
was minimal confirming stability of eGFR [5 mL/min per
1.73 m2 (2 to 11 mL/min per 1.73 m2)]. Our final CKD
algorithm consisted of 11 codes (with the performance of
individual codes and other algorithms presented in Table 2
and Additional file 1). This was an efficient algorithm, as
the sensitivity decreased by less than 1.5% while there was
an increase in both specificity and positive predictive value
compared to the algorithm that used any one of the 55
codes (results of the algorithm of any 55 codes presented
in Additional file 1). Using our final algorithm, a total of
9501 (7.7%) patients were classified positive for the CKD
database algorithm. The sensitivity of the CKD algorithm
for the detection of an eGFR <45 mL/min per 1.73 m2
was 32.7% (95% CI: 32.0 to 33.3%) and the specificity was
96.9% (95% CI: 96.7 to 97.0%). The positive predictive
value was 65.4% (95% CI: 64.4 to 66.3%) and negative pre-
dictive value was 88.8% (95% CI: 88.6 to 89.0%). When the
cohort was restricted to patients with an outpatient serum
creatinine value only, we found the performance of the
algorithm was not appreciably different (see Additional
file 1). Additionally, when at least two codes were
required in the look-back window, the sensitivity
decreased by approximately 14%, however the positive
predictive value increased compared to when at least
one code was used.
The validity of the algorithm for detection of the
additional eGFR thresholds (<60 and <30 mL/min per
1.73 m2) is presented in Table 3. Algorithm sensitivity
increased to 58.8% for the detection of more pronounced
CKD (eGFR <30 mL/min per 1.73 m2).
Table 2 Performance of each of the 11 codes in the final CKD algorithm
Code Description Sensitivity Specificity PPV NPV
ICD10 E102 Type 1 diabetes mellitus with incipient
diabetes nephropathy adequately or inadequately
controlled by insulin, diet, or oral agents
0.17% 99.99% 69.57% 84.63%
ICD10 E112 Type 2 diabetes mellitus with incipient
diabetes nephropathy adequately or inadequately
controlled by insulin, diet, or oral agents
5.55% 99.42% 63.73% 85.26%
ICD10 E132 Other specified diabetes mellitus with
incipient diabetes nephropathy adequately or
inadequately controlled by insulin, diet, or oral agents
0.01% 100.00% 100.00% 84.61%
ICD10 E142 Unspecified diabetes mellitus with incipient
diabetes nephropathy adequately or inadequately
controlled by insulin, diet, or oral agents
0.86% 99.92% 67.49% 84.71%
ICD10 I12 Hypertensive renal disease 7.20% 99.60% 76.64% 85.50%
ICD10 I13 Hypertensive renal and heart disease 0.49% 99.98% 78.15% 84.67%
ICD10 N08 Glomerular disorders in diseases classified elsewhere 3.75% 99.75% 73.48% 85.07%
ICD10 N18 Chronic renal failure 12.24% 99.45% 80.08% 86.17%
ICD10 N19 Unspecified renal failure 4.51% 99.58% 66.38% 85.14%
OHIP DX 403 Hypertensive renal disease 3.08% 99.74% 68.02% 84.98%
OHIP DX 585 Chronic renal failure, uremia 22.39% 98.20% 69.35% 87.43%
Abbreviations: ICD10, International Classification of Diseases, 10th revision; OHIP DX, Ontario Health Insurance Plan diagnostic codes; PPV, positive predictive value;
NPV, negative predictive value. Results are presented for the detection of an eGFR < 45 mL/min per 1.73 m2.
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coding algorithm the median (IQR) serum creatinine
value was 135 μmol/L (106 to 179 μmol/L) and for those
who were algorithm negative, the value was 82 μmol/L
(69 to 98 μmol/L). Similar trends were seen with eGFR;
algorithm positive patients had an eGFR of 38 ml/min
per 1.73 m2 (26 to 51 ml/min per 1.73 m2) and algorithm
negative patients had a value of 69 ml/min per 1.73 m2
(56 to 82 ml/min per 1.73 m2).
Performance of the CKD algorithm stratified by age
and sex is presented in Table 4. Algorithm sensitivity
was lower in women compared to men (25.7 vs. 43.7%;
p <0.001) and in the oldest patients (over 80 vs. 66 to
80; 28.4 vs. 37.6%; p <0.001). Men who were algorithm
positive had a median (IQR) eGFR similar to algorithm
positive women [40 (28 to 53) vs. 36 (25 to 49) mL/min
per 1.73 m2]. Patients in the oldest age category (>80 years)Table 3 Diagnostic performance characteristics of the
final algorithm for other thresholds of chronic kidney
disease
<60 ml/min per 1.73 m2 <30 ml/min per 1.73 m2
% (95% CI) % (95% CI)
Sensitivity 18.0 (17.7-18.4) 58.8 (57.4-60.1)
Specificity 98.2 (98.1-98.3) 94.6 (94.5-94.7)
PPV 85.2 (84.5-85.9) 32.5 (31.6-33.5)
NPV 67.7 (67.4-68.0) 98.1 (98.0-98.2)
Abbreviations: PPV, positive predictive value; NPV, negative predictive value;
CI, confidence interval.who were positive for the CKD algorithm had a median
(IQR) eGFR of 34 mL/min per 1.73 m2 (25 to 45 mL/min
per 1.73 m2) compared to 41 ml/min per 1.73 m2 (29 to
55 mL/min per 1.73 m2) in algorithm positive patients in
the second oldest age category (66 to 80 years).
Discussion
We developed and assessed the accuracy and validity of
algorithms that used hospital encounter and physician
claim codes from population-based administrative data in
Ontario, Canada to detect CKD. Older patients identified
as having CKD by the final database algorithm had higher
serum creatinine values and lower eGFR values than those
without such codes. Similar to previous studies, our final
algorithm demonstrated a high specificity and negative
predictive value [6,7]. For example, the specificity was high
(>92%) for all eGFR thresholds and stratified analyses. The
high negative predictive value (88.8% for the main eGFR
threshold) provides confidence that individuals who are
algorithm negative most likely do not have CKD.
The range of sensitivities reported in other CKD
validation studies has been broad [6,7]. Our algorithm
demonstrated 33% sensitivity for detecting an eGFR
<45 mL/min pre 1.73 m2, and resulted in an appreciable
underestimation of disease. In both the current study and
a recent study done in Alberta, Canada sensitivity was
lowest for detecting milder forms of CKD and improved
with disease severity [7]. As coding relies on recorded
diagnoses, physicians may be less likely to recognize or
act on mild CKD. As well, in both studies algorithm
Table 4 Performance of the CKD algorithm by age and sex
Sensitivity Specificity PPV NPV
% (95% CI) % (95% CI) % (95% CI) % (95% CI)
66-80 years old 37.6 (36.6-38.6) 97.1 (97.0-97.2) 59.1 (57.9-60.4) 93.3 (93.1-93.5)
>80 years old 28.4 (27.5-29.2) 96.1 (95.8-96.3) 74.5 (73.1-75.8) 76.8 (76.4-77.3)
Code Positive Code Negative
eGFR (mL/min per 1.73m2) Creatinine (μmol/L) eGFR (mL/min per 1.73m2) Creatinine (μmol/L)
66-80 years old 41 (29–55) 133 (104–176) 73 (60–85) 81 (69–95)
>80 years old 34 (25–45) 140 (109–183) 58 (46–72) 87 (71–106)
Sensitivity Specificity PPV NPV
% (95% CI) % (95% CI) % (95% CI) % (95% CI)
Men 43.7 (42.5-44.8) 96.0 (95.8-96.2) 62.0 (60.6-63.3) 91.9 (91.7-92.1)
Women 25.7 (24.9-26.5) 97.6 (97.5-97.7) 69.4 (68.0-70.8) 86.2 (86.0-86.5)
Code Positive Code Negative
eGFR (mL/min per 1.73m2) Creatinine (μmol/L) eGFR (mL/min per 1.73m2) Creatinine (μmol/L)
Men 40 (28–53) 145 (115–190) 72 (59–83) 90 (79–106)
Women 36 (25–49) 123 (95–164) 67 (53–81) 74 (64–89)
Abbreviations: ICD-10, International Classification of Diseases, 10th revision; OHIP, Ontario Health Insurance Plan; PPV, positive predictive value; NPV, negative
predictive value; CI, confidence interval.
Dichotomous results are presented for a reference eGFR < 45 mL/min per 1.73 m2.
Numbers listed are median (interquartile range).
Creatinine was measured in serum.
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in older compared to younger elderly patients. These are
segments of the population where CKD has traditionally
been unrecognized [23]. Differences in code validity by
age and sex may lead to biased estimates when assessing
CKD risk in certain populations using the database
algorithm. In general, the algorithm seems most useful
when assessing CKD as a baseline characteristic and when
it is not a main variable in an analysis. Given limits in
sensitivity, the CKD coding algorithm is also less useful as
an outcome measure.
We recently published a systematic review of 19 studies
on the validity of algorithms of healthcare administrative
database codes to detect CKD [6]. Across the studies,
patients were accrued from 1984 to 2004 and some
studies included CKD defined by the receipt of dialysis.
Most of the studies used an ICD-9 version of the codes.
The four studies validating ICD-10 codes for CKD used
the reference standard of chart review. This differs from
the current study where the preferred reference standard
of laboratory values was employed.
Our study has other strengths. The validation follows
guidelines set out for studies of diagnostic accuracy [10].
As well, all individuals in Canada receive universal
health care. This provided us with access to information
from a large number of patients which resulted in esti-
mates with good precision.
Our study does have some limitations. We used a
pragmatic approach to algorithm development and onlycombined codes using the Boolean operator “OR”. We
also only defined codes as absent or present based on a
fixed window of being present at least once in the prior
five years. While we did also assess our main algorithm
looking for two codes in the look-back, we found that
the loss in sensitivity was not worth the small gain in
positive predictive value. Additional efforts could consider
more refined methods of combining codes, and or different
algorithms focused on maximizing a single performance
measure such as specificity. Combining codes could also
be done with machine learning which takes information
from a variety of sources in an automated fashion to
compile the most efficient algorithms [24].
We were interested in developing an algorithm to detect
a reduced eGFR. Estimated GFR is the most important
parameter of CKD. In clinical practice, two measurements
separated by at least three months are required to confirm
its presence, while in this study we assessed eGFR at a
single point in time (although the single value was
stable in the subset of patients with another baseline
measurement). It might be useful in the future to develop
different algorithms for different levels of low eGFR. As
well, the algorithm may not be useful for detecting CKD
defined by proteinuria in the absence of low eGFR.
We did not split our sample into derivation and valid-
ation subsets. Rather, to confirm similar performance our
final CKD algorithm should be tested in other regions and
be re-examined in our region at a future time. It is
possible that similar physician claim codes included in the
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in jurisdictions without universal health care or without
a fee-for-service model. The algorithm should also be
validated in younger patients where CKD is less prevalent
and serum creatinine testing is less common [25-27].
Finally, it must be recognized that any algorithm will
fail to capture individuals who have CKD but do not have
a laboratory test to identify its presence in routine care.
Conclusion
We have described the diagnostic properties of an
algorithm to detect CKD in the large healthcare adminis-
trative databases of Ontario, Canada. This algorithm can
be used for health services research and population
disease surveillance when serum creatinine results are
unavailable. However, the algorithm should be used
judiciously given its limited sensitivity.
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